Major stock market indexes were down on Monday but closed well above their worst levels of the day. A healthcare stock was one of the best performers on the day.
Transaction boosts Solta Medical's position to meet rising demand in China's growing aesthetics market LAVAL, QC / ACCESS Newswire / December 1, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)
Handelsbanken Fonder AB lowered its position in Bausch Health Cos Inc. (NYSE: BHC) by 20.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and E
LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced the commencement of offers to exchange the Company

Bausch (BHC) Upgraded to Buy: Here's Why

01:01pm, Wednesday, 19'th Nov 2025
Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, wil
Dr. Reddy's Laboratories (NYSE: RDY - Get Free Report) and Bausch Health Cos (NYSE: BHC - Get Free Report) are both medical companies, but which is the better investment? We will compare the two busin
Insights from John Paulson (Trades, Portfolio)'s Third Quarter 2025 13F Filing John Paulson (Trades, Portfolio) recently submitted the 13F filing for the third
Acadian Asset Management LLC increased its position in Bausch Health Cos Inc. (NYSE: BHC) by 16.2% in the second quarter, according to the company in its most recent filing with the Securities and Exc
Bausch + Lomb CEO Brent Saunders joins 'Squawk Box' to preview the company's investor day, details of the company's three-year plan for profitable growth, impact of tariffs, and more.
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will outline the next chapter
Bausch Health (BHC) delivered a strong Q3, exceeding expectations and reinforcing the medium-term deleveraging investment thesis. BHC's upside potential is now 36.8%, with a Buy rating maintained and
Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FFW (OTCMKTS:FFWC - Get Free Report) and Pathfinder Bancorp (NASDAQ: PBHC - Get Free Report) are both small-cap finance companies, but which is the better business? We will contrast the two businesses
Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL, QC / ACCESS Newswire / November 5, 2
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE